To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Adam Schechter successfully led ...
The pandemic provided an unprecedented growth opportunity in diagnostic testing. COVID-19 tests took off, first, at testing sites — and later at home, Labcorp (LH) CEO Adam Schechter told Yahoo ...
StockStory.org on MSN
The 5 most interesting analyst questions from Labcorp’s Q1 earnings call
Labcorp’s first quarter was marked by continued growth in both its Diagnostics and Biopharma Laboratory Services businesses, ...
Labcorp CEO Adam Schechter gives Barron’s a rundown of the diagnostic giant’s technology-first transformation.
Labcorp is raising its 2026 guidance, buoyed by demand across its diagnostics and central laboratory businesses. | Labcorp is ...
Q1 2026 earnings call: revenue +6%, EPS +11%, margin gains and raised 2026 guidance amid policy risks (PAMA/ACA).
Labcorp CEO Adam Schechter said on Closing Bell that vaccine recipients are not being advised to be tested for COVID-19 antibodies after immunization, reported CNBC. There have been questions about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results